Make This Move Before Nvidia's Critical Update (Unique Play)
Nvidia's CEO is about to say five simple words that could ignite the next explosive phase of the AI boom. It's not about tariffs or China--but it could change everything. This moment could define the biggest profit wave yet.
Financials
| Curr Year EPS Estimate | 4.83 |
| Next Quarter EPS Estimate | 5.80 |
| Profit Margin | 11.86% |
| Operating Margin | 14.63 |
| Return on Assets | 0.04 |
| Return on Equity | 0.12 |
| Revenue | 4.1B |
| Earnings Per Share | 7.36 |
| Revenue Per Share | 66.15 |
| Gross Profit | 3,745,913,088 |
| Quarterly Revenue Growth | -0.01 |
General
| Name | Jazz Pharmaceuticals plc |
| Ticker | JAZZ |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 2,800 |
About Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Xyrem for the treatment of cataplexy or EDS with narcolepsy; Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma; Enrylaze to treat acute lymphoblastic leukemia and lymphoblastic lymphoma; Zepzelca for the treatment of metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy; Ziihera to treat HER2-positive biliary tract cancers; Defitelio to treat severe veno-occlusive disease; and Vyxeos for the treatment of newly-diagnosed therapy-related acute myeloid leukemia. It also develops Zanidatamab in Phase 3 trial to treat HER2-expressing gastroesophageal adenocarcinoma (GEA), and patients with HER2-expressing metastatic GEA; Epidiolex in Phase 3 trial to treat LGS, DS, and TSC; Suvecaltamide in Phase 2 trial to treat Parkinson's disease tremor; JZP815, a pan-RAF kinase inhibitor in Phase 1 trial that targets components of the mitogen-activated protein kinase; JZP898, a conditionally activated interferon alpha molecule in Phase 1 trial; JZP441 in Phase 1 trial to treat narcolepsy, IH, and other sleep disorders; JZP324, an extended-release low sodium oxybate formulation in Phase 1 trial for patients with sleep disorders; and JZP150 to treat post-traumatic stress disorder. The company has licensing and collaboration agreements with Redx Pharma plc, Autifony Therapeutics Limited, Zymeworks Inc., Sumitomo Pharma Co., Ltd., and Werewolf Therapeutics, Inc. Jazz Pharmaceuticals plc was founded in 2003 and is headquartered in Dublin, Ireland.
Earnings
Female HR exec caught on Coldplay cam resigns after embrace with CEO went viral
The female executive who was caught on camera embracing the CEO of her company at a Coldplay concert in a moment that went viral has resigned, according to news reports.
Cars.com Stock: Structural Recovery Lacks Confirmation
CARS is in Phase 11 of its Adhishthana Cycle. While it may look like a value buy, the real bullish structure is still incomplete
Trump Signals "End of M.A.G.A." - Ad
Trump's new mission: Make America Wealthy Again. And according to ex-CIA advisor Jim Rickards, the U.S. is sitting on a $150 trillion fortune--enough to make every family millionaires. Discover how this hidden wealth could soon change everything.
Ulta Stock Is The Beyoncé Of Retail Now: LVMH's Just A Backup Dancer
LVMH is struggling to find its footing. Ulta, meanwhile, is delivering to consumers affordable, feel-good indulgence with staying power.
Trump Says 5 Jets Downed During India-Pakistan Conflict: '...Shot Out Of The Air'
President Donald Trump during a dinner with Republican lawmakers stated, that up to 5 jets were shot down during the India-Pakistan conflict.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Fires engulf Turkey's Mediterranean coast as government declares 2 disaster zones
ISTANBUL (AP) — New wildfires broke out on Turkey’s Mediterranean coast Friday, as the government declared two western provinces in to be disaster zones.
Jim Cramer Made 'FAANG' Popular, Now He Says There's A New Acronym To Describe These Retail Favorite Stocks — 'PARC'
Renowned TV host Jim Cramer is stirring chatter on X with another buzzworthy "meme stock" acronym, aimed at a new group of retail-favorite stocks that are defying gravity.
Putting Your Name on This List Could Hand You $1,270 on Friday - Ad
URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.
Texas AG claimed three homes as primary residence. Democrats are being probed for similar issue
WASHINGTON (AP) — Texas Attorney General Ken Paxton and his wife, Angela, are longtime owners of a $1.5 million house in a gated community outside Dallas. In 2015, they snapped up a second home in Austin. Then another.
Alphabet (Google) Q2 Earnings Preview: Market Expert Says Mag 7 Stock 'Has Been Anything But' Magnificent
Alphabet stock trades nearly flat year-to-date in 2025. A strong Q2 report could see shares trade higher and closer to all-time highs.
Warren Buffett's Investing Partner's Shocking Final Move - Ad
Before he passed away, Charlie Munger, Warren Buffett's investing partner of 60 years, was rumored to have quietly made one final investment... Up until now, it has remained hidden from the public. It's potentially the smartest, most profitable, and most under-valued AI investment you can make today.
The Latest Wave of AI Investments and Acquisitions: Perplexity AI Secures Landmark Funding As Amazon And Stripe Make Moves
Latest AI news: Funding surges, key acquisitions by Amazon & Stripe, and major moves from startups like Perplexity AI & BrightAI.
Business News Digest
AP Business Digest
What's inside Elon's building in Memphis will shock you - Ad
Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the July 1st funding window closes.
Trump's Backroom Billionaire: Bezos Meets As SpaceX Fades
President Donald Trump reportedly meets with Jeff Bezos as ties with SpaceX's Elon Musk evaporate.
Trump's Megabill Brings Tax Breaks for the Wealthy and Welfare Cuts — Here's How Your Income Taxes Could Change
President Trump signed his massive spending and social policy bill into law during an Independence Day event at the White House on Friday.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Tea-loving Nepal is warming up to coffee
KATHMANDU, Nepal (AP) — Coffee hasn't always been an easy sell in .
Larry Ellison Couldn't Afford His Electric Bill Once Upon A Time — In 2025 He's Added Nearly $100 Billion To His Net Worth, Surpassing The Likes Of Jeff Bezos And Mark Zuckerberg
Larry Ellison, once too broke to pay his utility bills, has added nearly $100 billion to his net worth in 2025 alone—surpassing Jeff Bezos and Mark Zuckerberg—thanks to Oracle's meteoric rise and his strategic bets on cloud and AI.
Apple's Secret Weapon to Disrupt a $9 Trillion Industry - Ad
Apple just fired a shot at a $9 trillion sector - not with a new iPhone, but with its most disruptive project since the smartphone. One tiny supplier - still trading near $30 - sits quietly at the center of this bold move.
Ozempic, Mounjaro Users Cut $6.5 Billion From Grocery Bills: GLP-1 Boom Triggers Panic In Packaged Food Aisles
GLP-1 medications are delivering a $6.5 billion blow to U.S. grocery spending, with weight-loss drugs altering consumer purchasing patterns.
Edmunds: Five expert tips to make cross-country EV driving easy
The idea of a cross-country road trip in an electric vehicle might seem daunting. After all, it’s not hard to envision getting stranded on the side of the road with a depleted battery or being stuck in a parking lot, charging for hours. But there are ways to easily avoid these worst-case scenarios. The experts at Edmunds have plenty of experience driving electric vehicles, and here they share their five best tips on how to make cross-country driving in an EV easy.
Buffett's Favorite Chart Just Hit 209% - Here's What That Means For Gold - Ad
Buffett's favorite market signal just hit its highest level in history-stocks are more overvalued than 1929. He's sitting on $325B in cash... and may be about to buy one overlooked gold miner. I've identified it-plus 4 others with up to 100X potential.
After years of tough rules on liquids and footwear, US air travel may be on the cusp of a new era
NEW YORK (AP) — When limits on liquids were introduced at TSA checkpoints across the country in 2006, bins overflowed with bottled water, toothpaste, shaving cream and so much more. Nearly two decades later, travelers are much more accustomed to the “3-1-1” regulations" governing the size of the liquids they're flying with, but scenes of passengers guzzling a beverage before putting their bags through the screening machines are still common.
Rigetti Computing, Netflix, Johnson & Johnson, United Airlines And ASML: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks moved higher today, with the Dow Jones gaining more than 200 points, or 0.5%, to close at 44,254.78.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Charles Schwab To Launch Bitcoin, Ethereum Trading Services
Charles Schwab (NYSE:SCHW), one of the largest brokerage firms in the United States, has confirmed plans to launch Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO:
AMD Stock Is Sliding Tuesday: What's Driving The Action?
Shares of Advanced Micro Devices are trading lower Tuesday afternoon. The stock is caught in a broader downturn affecting the semiconductor industry.
Make This Move Before Nvidia's Critical Update (Unique Play) - Ad
Nvidia's CEO is about to say five simple words that could ignite the next explosive phase of the AI boom. It's not about tariffs or China--but it could change everything. This moment could define the biggest profit wave yet.
Peter Thiel Effect? Cathie Wood Pours $175 Million Into Bitmine Immersion Stock As Founders Fund Backing, Ethereum Spike Fuels Buzz
Ark Invest, led by Cathie Wood, made significant trades on Monday.
Chrysler, Jeep Parent Company Stellantis Expects $2.7 Billion Net Loss In First Half Of 2025 As Trump Tariffs Cause Uncertainty
Stellantis' preliminary financial results for H1 2025 predicts a $2.68B net loss due to declines in shipments, tariffs and lower fleet sales.
Trump Signals "End of M.A.G.A." - Ad
Trump's new mission: Make America Wealthy Again. And according to ex-CIA advisor Jim Rickards, the U.S. is sitting on a $150 trillion fortune--enough to make every family millionaires. Discover how this hidden wealth could soon change everything.
Carvana Stock Outlook: Cautious Optimism Warranted
Carvana is in Phase 11 of its Adhishthana Cycle. Read what's driving the rally and why investors may want to stay a little cautious.
Is Costco Stock Topping Out? Key Price Levels To Watch
Costco stock (COST) may have formed a long-term peak. Adhishthana Principles suggest the next move could define the stock's future trajectory.
Leaked Memo Points to $100 Trillion Wealth Transfer Starting Soon - Ad
The U.S. Department of the Interior's internal memo has leaked ... and the contents are shocking. A federally backed resource monetization plan may soon go live, and it could trigger a new gold rush into select energy and mineral stocks. Investing legend Whitney Tilson breaks it all down inside.
Takeaways from AP's report about cuts to government grants for nonprofits
President Donald Trump's policies are poised to the federal government has built with nonprofits to help people in their communities.
Anti-Trump Climate Protesters Storm NYC Apple Store, Confront CEO Tim Cook Amid Texas Flood Crisis
Demonstrators gathered inside and outside of New York City's 5th Avenue Apple store on Sunday to denounce big tech companies for backtracking on their previous support of the Paris Climate Agreement and to protest the Trump administration.
Putting Your Name on This List Could Hand You $1,270 on Friday - Ad
URGENT: On Tuesday, a simple set of instructions will be sent out to an elite group of investors. The folks in this group will have the opportunity to place a 10-minute trade that could double their money by Friday. Consider this your invitation to join them. The next trade is just days away.
Degrees No Longer 'Get‑A‑Job‑Free' Cards, Shows Survey — Gen Z Has College Regrets, Here's Why
Gen Z workers regret college and wish for higher-paying majors. Degrees don't guarantee jobs and cost is a concern. Parents are supporting alternatives.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.